| Proportion of high risk comorbidities | |
| Age group “18–29” | 30.1% |
| Age group “30–49” | 39.4% |
| Age group “50–64” | 60.2% |
| Age group “65–74” | 78.3% |
| Age group “75+” | 90.8% |
| Probability infection being symptomatic (%) in 2022 | |
| Age group “18–29” | 3.1% |
| Age group “30–49” | 4.9% |
| Age group “50–64” | 3.9% |
| Age group “65–74” | 4.3% |
| Age group “75+” | 6.0% |
| Hospitalization rate among symptomatic patients (%) in 2022 | |
| Age group “18–29” | 0.3% |
| Age group “30–49” | 0.6% |
| Age group “50–64” | 1.6% |
| Age group “65–74” | 3.5% |
| Age group “75+” | 1.0% |
| Risk for hospitalization of with comorbidities patient group | 2.6% |
| Risk for hospitalization of NON comorbidities patient group | 0.5% |
| Critical care/ICU admission rate among hospitalized patients (%) in 2022 | |
| Age group “18–29” | 12.1% |
| Age group “30–49” | 13.7% |
| Age group “50–64” | 21.8% |
| Age group “65–74” | 25.1% |
| Age group “75+” | 15.1% |
| Risk for ICU of with comorbidities patient group | 0.4% |
| Risk for ICU of with NON comorbidities patient group | 0.1% |
| Probability of death among patients on normal ward (%) in 2022 | |
| Age group “18–29” | 1.2% |
| Age group “30–49” | 1.1% |
| Age group “50–64” | 5.7% |
| Age group “65–74” | 12.0% |
| Age group “75+” | 22.4% |
| Risk for death in GW of with comorbidities patient group | 10.4% |
| Risk for death in GW of NON comorbidities patient group | 4.6% |
| Probability of death among patients on critical care (%) in 2022 | |
| Age group “18–29” | 9.1% |
| Age group “30–49” | 14.7% |
| Age group “50–64” | 25.4% |
| Age group “65–74” | 55.2% |
| Age group “75+” | 52.1% |
| Risk for death in ICU of with comorbidities patient group | 35.3% |
| Risk for death in ICU of NON comorbidities patient group | 41.0% |
| Probability of death among patients on outpatient care (%) in 2022 | |
| Age group “18–29” | 0.0% |
| Age group “30–49” | 0.0% |
| Age group “50–64” | 0.2% |
| Age group “65–74” | 0.7% |
| Age group “75+” | 3.7% |
| Risk for death outpatient of with comorbidities patient group | 0.5% |
| Risk for death outpatient of NON comorbidities patient group | 0.0% |